Anti-hypoxia Treatments to Reprogram The Tumor Microenvironment & Improve Cancer Immunotherapies

Time: 10:10 am
day: Day One


• Addressing the acute need in strategies to target the most upstream stage of the hypoxia- A2-adenosinergic pathway of immunosuppression in the tumor microenvironment (TME)

• Emphasizing reprogramming the TME by eliminating tumor hypoxia to improve outcomes of current cancer immunotherapies